Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $411.05 million. The enterprise value is $283.53 million.

Market Cap	411.05M
Enterprise Value	283.53M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

NMRA has 182.69 million shares outstanding. The number of shares has increased by 2.52% in one year.

Current Share Class	182.69M
Shares Outstanding	182.69M
Shares Change (YoY)	+2.52%
Shares Change (QoQ)	+4.13%
Owned by Insiders (%)	4.53%
Owned by Institutions (%)	36.50%
Float	105.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.77
P/TBV Ratio	3.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.87, with a Debt / Equity ratio of 0.53.

Current Ratio	5.87
Quick Ratio	5.62
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-73.36

Financial Efficiency

Return on equity (ROE) is -121.21% and return on invested capital (ROIC) is -65.92%.

Return on Equity (ROE)	-121.21%
Return on Assets (ROA)	-58.11%
Return on Invested Capital (ROIC)	-65.92%
Return on Capital Employed (ROCE)	-148.90%
Weighted Average Cost of Capital (WACC)	19.42%
Revenue Per Employee	n/a
Profits Per Employee	-$2.47M
Employee Count	96
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NMRA has paid $130,000 in taxes.

Income Tax	130,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +197.03% in the last 52 weeks. The beta is 3.12, so NMRA's price volatility has been higher than the market average.

Beta (5Y)	3.12
52-Week Price Change	+197.03%
50-Day Moving Average	2.66
200-Day Moving Average	2.17
Relative Strength Index (RSI)	47.83
Average Volume (20 Days)	1,428,972

Short Selling Information

The latest short interest is 4.47 million, so 2.45% of the outstanding shares have been sold short.

Short Interest	4.47M
Short Previous Month	4.33M
Short % of Shares Out	2.45%
Short % of Float	4.25%
Short Ratio (days to cover)	3.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-236.16M
Pretax Income	-236.80M
Net Income	-236.93M
EBITDA	-235.95M
EBIT	-236.16M
Earnings Per Share (EPS)	-$1.45

Full Income Statement

Balance Sheet

The company has $182.53 million in cash and $55.01 million in debt, giving a net cash position of $127.52 million or $0.70 per share.

Cash & Cash Equivalents	182.53M
Total Debt	55.01M
Net Cash	127.52M
Net Cash Per Share	$0.70
Equity (Book Value)	103.87M
Book Value Per Share	0.60
Working Capital	158.09M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-206.44M
Capital Expenditures	n/a
Depreciation & Amortization	208,000
Net Borrowing	57.16M
Free Cash Flow	-206.44M
FCF Per Share	-$1.13

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.52%
Shareholder Yield	-2.52%
Earnings Yield	-57.64%
FCF Yield	-50.22%

Analyst Forecast

The average price target for NMRA is $7.50, which is 233.33% higher than the current price. The consensus rating is "Buy".

Price Target	$7.50
Price Target Difference	233.33%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1